Tesofensine: What CNS-Targeting Obesity Research Shows (2026)
Last Updated: May 2026Author: Dr. Alexander Isaacs, Lead Research AdvisorCredentials: Ph.D. in Neuropharmacology, over 15 years analyzi...
Vilon Peptide – Immune Benefits, Mechanism & Dosage Guide
FDA Compliance Notice: Vilon is an investigational research compound not approved by the FDA or EMA for human use. For the full legal a...
Tirzepatide: Dual Incretin Mechanism and What the Clinical Evidence Shows
Tirzepatide differs from most of the molecules discussed in this section. This is because it is no longer an investigational peptide in...
Tesamorelin: Benefits, Side Effects, Mechanism & Metabolic Research
Tesamorelin Peptide: Research on Visceral Fat Reduction, GH Axis, and Metabolic Benefits
The following is provided for informational...
Ipamorelin: What Research Shows About Selective GH Secretion
Among growth hormone secretagogues, ipamorelin has one characteristic that has made it the subject of particular attention, as document...
Hexarelin Long-Term Research: GH Effects Beyond Short-Term Data
Updated: May 2026Written by Dr. Alexander Isaacs, Lead Researcher
Disclaimer: This information is for educational purposes only, not...
CJC-1295 Research: What Studies Show About the GHRH Analog
Among GHRH analogs, CJC-1295 holds a special place. Why this one and not the dozens of other peptides? Because, unlike most peptides cu...
Glutathione Benefits & Side Effects – Full Supplement Guide 2026
Medical Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical ad...
The mTOR Pathway in Peptide Research: Growth, Aging, and Cellular Signaling
There are molecular switches that cells use to decide whether to grow or conserve resources literally. mTOR is one of them and perhaps ...
What Is Tesofensine? A Research Compound for Appetite and Weight Management Explored
Among the compounds studied for appetite regulation and weight management, tesofensine occupies a somewhat unusual position. The fact i...